Delivery Order SPE2DR25D3002-SPE2DR26FVYM1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,852.74. This is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. The contract will be completed by January 21, 2026, and the products will be delivered to the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,185.93 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by September 18, 2025, and will be fulfilled from the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.37 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, awarded on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The point of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $1,174.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. The contract, designated as a non-set-aside competitive award, is scheduled for completion by December 1, 2025, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,296.00. The contract was competitively awarded without set-aside provisions and is classified as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will be based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,112.63. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by November 28, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, valued at $4,376.89 with an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 27, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,823.83 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on November 5, 2025, with completion targeted for November 6, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages with a ceiling value of $1,944.00. This is a firm fixed-price delivery order awarded without set-aside designation on December 29, 2025, with an ultimate completion date of December 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office and primary distribution...
- The Defense Logistics Agency awarded a $2,272.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of October 23, 2025. This non-set-aside competitive award was issued on October 22, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where...
- SPE2DR25D3002Indefinite Delivery Contract
- SPE2DR25D3002-SPE2DR26FVYM1Delivery Order
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp on January 23, 2026, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,276.51. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by January 26, 2026, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including the Department of Defense and military treatment facilities. This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The hormone treatment order exemplifies the company's role as a critical vendor for federal military healthcare procurement across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/22/26 |